CUPID2023-10-012023-12-31 CUPID2023-10-012023-12-31 CUPID2023-10-012023-12-31in-bse-fin:OneOperatingExpenses01Member CUPID2023-10-012023-12-31in-bse-fin:FourOperatingExpenses01Member CUPID2023-12-31 CUPID2023-10-012023-12-31in-bse-fin:OneReportableSegmentRevenue01Member CUPID2023-10-012023-12-31in-bse-fin:OneReportableSegmentRevenue02Member CUPID2023-10-012023-12-31in-bse-fin:OneReportableSegmentRevenue03Member CUPID2023-10-012023-12-31in-bse-fin:FourReportableSegmentRevenue01Member CUPID2023-10-012023-12-31in-bse-fin:FourReportableSegmentRevenue02Member CUPID2023-10-012023-12-31in-bse-fin:FourReportableSegmentRevenue03Member CUPID2023-10-012023-12-31in-bse-fin:OneReportableSegmentResults01Member CUPID2023-10-012023-12-31in-bse-fin:OneReportableSegmentResults02Member CUPID2023-10-012023-12-31in-bse-fin:OneReportableSegmentResults03Member CUPID2023-10-012023-12-31in-bse-fin:FourReportableSegmentResults01Member CUPID2023-10-012023-12-31in-bse-fin:FourReportableSegmentResults02Member CUPID2023-10-012023-12-31in-bse-fin:FourReportableSegmentResults03Member CUPID2023-10-012023-12-31in-bse-fin:OneReportableSegmentAssets01Member CUPID2023-10-012023-12-31in-bse-fin:OneReportableSegmentAssets02Member CUPID2023-10-012023-12-31in-bse-fin:OneReportableSegmentAssets03Member CUPID2023-10-012023-12-31in-bse-fin:OneReportableSegmentLiabilities01Member CUPID2023-12-31in-bse-fin:OneReportableSegmentLiabilities01Member CUPID2023-10-012023-12-31in-bse-fin:OneReportableSegmentLiabilities02Member CUPID2023-12-31in-bse-fin:OneReportableSegmentLiabilities02Member CUPID2023-10-012023-12-31in-bse-fin:OneReportableSegmentLiabilities03Member CUPID2023-12-31in-bse-fin:OneReportableSegmentLiabilities03Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 530843 CUPID NOTLISTED Cupid Limited Equity 2023-04-01 2024-03-31 2024-01-23 2024-01-05 INR Lakhs Third quarter 16:30:00 20:25:00 2024-01-23 2024-01-23 Not applicable Multi segment 2023-10-01 2023-12-31 Unaudited Standalone 400516000.00 7281000.00 407797000.00 130819000.00 0.00 32844000.00 31391000.00 3908000.00 7520000.00 83971000.00 290453000.00 117344000.00 0.00 117344000.00 22978000.00 5730000.00 28708000.00 0.00 88636000.00 0.00 0.00 0.00 0.00 88636000.00 0.00 88636000.00 0.00 0.00 133380000.00 10 6.65 6.61 0.00 0.00 6.65 6.61 0.00 0.00 0.00 Notes to the Quarterly Result: - 1. The above financial results have been reviewed and recommended for approval by the Audit Committee to the Board of Directors and have been approved by the Board of Director at its meeting held on 23rd January, 2024. 2. Financial results for all the periods presented have been prepared in accordance with the recognition and measurement principle of lnd AS notified under the Companies (Indian Accounting Standard) Rules, 2015 as amended from time to time. 3. The company’s business operation comprises of operating segments viz., Male and Female contraceptives, other relevant products and In Vitro Devices (IVD). 4. The Board of Directors authorised Mr. Kuldeep Halwasiya, Chairman, to sign the standalone financial results of the company for quarter and nine months ended on 31st December, 2023. 5. During quarter ended 31st December, 2023, the Company has transferred unpaid and unclaimed dividend of INR 5,03,137 and 961 unclaimed shares to IEPF. 6. The previous period / year financial figures have been regrouped / rearranged wherever necessary to make them comparable. 7. The results of the Company are available for investors at https://www.cupidlimited.com/, https://www.nseindia.com/ and https://www.bseindia.com/ Place: Mumbai For and on behalf of Date: 23rd January, 2024 Cupid Limited Mr. Kuldeep Halwasiya (Chairman) Multi segment 2023-04-01 2023-12-31 Unaudited Standalone 1081913000.00 42358000.00 1124271000.00 402033000.00 0.00 -41968000.00 119175000.00 8691000.00 21885000.00 410699000.00 920515000.00 203756000.00 0.00 203756000.00 44692000.00 -2313000.00 42379000.00 0.00 161377000.00 0.00 0.00 0.00 0.00 161377000.00 -3322000.00 158055000.00 0.00 0.00 133380000.00 10 12.10 12.03 0.00 0.00 12.10 12.03 0.00 0.00 0.00 Manufacturing and Administrative Expenses 83971000.00 Manufacturing and Administrative Expenses 410699000.00 a) Male and Female Contraceptives & Jelly 390050000.00 b) In Vitro Devices (IVD) 10465000.00 c) Others / Unallocated 7281000.00 a) Male and Female Contraceptives & Jelly 1061314000.00 b) In Vitro Devices (IVD) 20599000.00 c) Others / Unallocated 42358000.00 407796000.00 1124271000.00 0.00 0.00 407796000.00 1124271000.00 a) Male and Female Contraceptives & Jelly 111274000.00 b) In Vitro Devices (IVD) -1210000.00 c) Others / Unallocated 7281000.00 a) Male and Female Contraceptives & Jelly 169112000.00 b) In Vitro Devices (IVD) -7714000.00 c) Others / Unallocated 42358000.00 117345000.00 203756000.00 0.00 0.00 0.00 0.00 117345000.00 203756000.00 a) Male and Female Contraceptives & Jelly 754385000.00 b) In Vitro Devices (IVD) 95556000.00 c) Others / Unallocated 1242237000.00 2092178000.00 0.00 2092178000.00 a) Male and Female Contraceptives & Jelly 247509000.00 b) In Vitro Devices (IVD) 7050000.00 c) Others / Unallocated 32574000.00 287133000.00 0.00 287133000.00 0.00 -4439000.00 0.00 -1117000.00 0.00 0.00